FLI1 and gastric adenocarcinoma: In the current study, we report that nuclear FLI1 expression decreases along the progression to adenocarcinoma, with preserved nuclear expression in normal antral and oxyntic glands and intestinal metaplasia, and decreased expression from low-grade dysplasia and high-grade dysplasia to the lowest expression in invasive gastric adenocarcinomas.